1Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction:a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 2004,53: 195-199.
2Urbich C, Dimmeler S. Endothelial progenitor cells:characterization and role in vascular biology. Circ Res, 2004,95:343- 353.
3Loomans CJ, De Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? Antioxid Redox Signal, 2005,7:1468-1475.
4Krankel N, Adams V, Linke A, et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol, 2005,25:698- 703.
5Chen YH, Lin SJ, Lin FY, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxiderelated but not oxidative stress-mediated mechanisms. Diabetes, 2007,56 :1559-1568.
6Gallagher KA, Liu ZJ,Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest, 2007,117 : 1249-1259.
7Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol, 2004,164 : 457-466.
8Ii M,Takenaka H, Asai J, et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res, 2006,98:697-704.
9Capla JM, Grogan RH, Callaghan MJ, et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg, 2007,119 : 59-70.
10Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation,adhesion, and incorporation into vascular structures. Circulation, 2002,106 : 2781-2786.
4Yang Q,Graham TE,Mody N,et al.Serum retinol binding protein contributes to insulin resistance in obesity and type 2 diabetes.Nature,2005,436:356-362.
5UK Prospective Diabetes Study(UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33).Lancet,1998,352:837-853.
6Huber SA,SakkinenP.Interleukin-6 exacerbates early atherosclerosis in mice.Thromb Vase Biol,1999,19:2364-2367.
7Yao-Borengasser A,Varma V,Bodles AM,et al.Retinol binding protein 4 expression in humans:relationship to insulin resistance,inflammation,and response to pioglitazone.J Clin Endocrinol Metab,2007,92:2590-2597.
8Ceriello A.Thia～olidinediones as anti-inflammatory and antiatherogenic agents.Diabetes Metab Res Rev,2008,24:14-26.
9Wang N,Verna L,Chen NO,et al.Constitutive activation of peroxisome proliferators-activated receptor-gamma suppresses proinflammatory adhesion molecules in human vascular endothelial cells.J Biol Chem,2002,277:34176-34181.
10Sprague AH,Khalil RA.Inflammatory cytokines in vascular dysfunction and vascular disease.Biochem Pharmacol,2009,78:539-552.
